Evidence map›Paper›PMID 42057863›Full record

ArticleHealth science reports2026

Association Between Polymorphisms rs11003125 and rs7096206 of the

Minane Nafissa Triande, Lassina Traore, Sidnooma Véronique Zongo, Teega-Wendé Clarisse Ouedraogo, Mousso Savadogo, Sanata Nadine Kiemde, Tegwindé Rébéca Compaore, Augustin Tozoula Bambara, Roger Arsène Sombie, Patoinewendé Denise Ilboudo and 4 more

Abstract read
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Minane Nafissa TriandeLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Lassina TraoreLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.ORCID https://orcid.org/0000-0003-4719-380X
Sidnooma Véronique ZongoLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Teega-Wendé Clarisse OuedraogoLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Mousso SavadogoLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Sanata Nadine KiemdeLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Tegwindé Rébéca CompaoreLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Augustin Tozoula BambaraUnité de Formation et de Recherche en sciences de la santé Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Roger Arsène SombieUnité de Formation et de Recherche en sciences de la santé Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Patoinewendé Denise IlboudoLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Albert Théophane YonliLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Bolni Marius NagaloDepartment of Pharmacology and Physiology University of Maryland School of Medicine Baltimore Maryland USA.
Florencia Wendkuuni DjigmaLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.
Jacques SimporeLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph KI-ZERBO Ouagadougou Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Hepatitis B virus (HBV) infection remains a major global health burden, with disease progression influenced by host genetic and immune factors, including variants in the mannose-binding lectin 2 (MBL2) gene. This study aimed to evaluate the association between MBL2 polymorphisms and clinical outcomes of HBV infection in a cohort from Burkina Faso. Method: A total of 74 participants were recruited in 2022, including individuals with chronic hepatitis B (CHB, Results: For rs11003125, the GC heterozygous genotype predominated (77%), followed by GG (16.2%) and CC (6.7%). For rs7096206, genotype frequencies were 43.2% (CC), 28.4% (CG) and 28.4% (GG). The rs7096206 GG genotype and G allele were strongly associated with infection resolution (OR = 0.02, 95% CI: 0.0002-0.3, Conclusion: From an exploratory perspective, the analysis of the rs11003125 and rs7096206 polymorphisms located in the promoter region of the MBL2 gene suggests their possible involvement in the progression of HBV infection. These preliminary results support the hypothesis of a potential functional role of this gene in HBV pathogenesis, while highlighting the need for further studies to confirm and clarify these associations.

Indexed as

Burkina FasogeneHBVMBL2polymorphisms

Identifiers

PMID42057863
PMCPMC13121845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.